ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 663337 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 663337; 2) Community: the network communities that were significantly associated with the response to NSC 663337; 3) Molecule: the relationships between components within communities and NSC 663337; 4) MDR: the compounds that were significantly associated with the NSC 663337.

NSC Compound Enrichment Correlation
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0462077035966088 0.31245079
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0462077035966088 0.14842342
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0462077035966088 0.061349573
NSC 744658 6-(p-toluenesulfonylaminoethyl)diquino-1,4-thiazine 0.0462077035966088 -0.1968108
NSC 747174 Null 0.0462077035966088 0.35563992
NSC 756169 GSK317314A 0.0462077035966088 0.23819651
NSC 758664 Sirolimus [USAN] 0.0462077035966088 0.1529224
NSC 758682 ARTENIMOL 0.0462077035966088 0.21047852
NSC 303769 Null 0.0480633950058471 0.24652663
NSC 622924 Null 0.0480633950058471 -0.15621262
Total:129  Current:126    [First] [Prev] [Next] [Last]